Castleview Partners »

Bioxcel Therapeutics shares owned by Castleview Partners

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Castleview Partners from 13F filings

Historical chart of Castleview Partners investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Castleview Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Castleview Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $274k 97k 2.82

More positions owned by Castleview Partners

Valued Advisers Tr Regan Fltg Rate
Ea Series Trust Alpha Arch 1-3 (BOXX)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Spdr Gold Tr Gold Shs (GLD)
Microsoft Corporation (MSFT)
Amgen (AMGN)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Ser Tr Prtflo S&p500 Hi (SPYD)
Nextera Energy (NEE)
Vaneck Etf Trust Clo Etf (CLOI)
Visa Com Cl A (V)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)

View all positions for Castleview Partners

Top funds holding Bioxcel Therapeutics

FMR
BlackRock
Vanguard Group
Ameriprise Financial
Geode Capital Management
Armistice Capital
Beacon Pointe Advisors
Susquehanna International
Morgan Stanley
Northern Trust
Charles Schwab Investment Management
UBS Group
Citadel Advisors
Wells Fargo & Company
Bank of New York Mellon

View all funds holding Bioxcel Therapeutics